合成路线1
该中间体在本合成路线中的序号:
(I) The reaction of isatoic anhydride (I) with 1-(3-aminopropyl)-4-phenylpiperazine (II) in DMF at 40-60 C gives the o-aminobenzamide derivative (III), which is then cyclized by the action of phosgene in refluxing chlorobenzene.
【1】
Kulp, R.A.; Hayao, S.; Havera, H.J.; Strycker, W.G.; Leipzig, T.J.; Hartzler, H.E.; New sedative and hypotensive 3-substituted 2,4(1H,3H)-quinazolinediones. J Med Chem 1965, 8, 6, 807.
|
【2】
Schut, R.N.; Hong, E.; TR-2515. Drugs Fut 1985, 10, 11, 929.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
(II) |
29798 |
3-(4-phenyl-1-piperazinyl)propylamine; 3-(4-phenyl-1-piperazinyl)-1-propanamine
|
|
C13H21N3 |
详情 |
详情
|
(III) |
29799 |
2-amino-N-[3-(4-phenyl-1-piperazinyl)propyl]benzamide
|
|
C20H26N4O |
详情 |
详情
|
合成路线2
该中间体在本合成路线中的序号:
(II) By condensation of trans-4-aminocyclohexanol (I) with isatoic anhydride (II) in hot (100 C) xylene to give 2-amino-N-(trans-4-hydroxycyclohexyl)benzamide (III) , m.p. 219.5-220 C, which is reduced with LiAlH4 in THF to (trans-4-hydroxycyclohexyl)(2-aminobenzyl)amine (IV) (oxalate, m.p. 185-6 C); this product is finally brominated with Br2 in acetic acid.
【1】
Kech, J.; Liebigs Ann Chem 1967, 707, 19, Suppl. 2, 107.
|
【2】
Castaner, J.; Armstrong, B.; Ambroxol. Drugs Fut 1976, 1, 3, 959.
|
【3】
Keck, J.; et al. (Dr. Karl Thomae GmbH); Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children. BE 0795585; DE 2207460; FR 2181742; GB 1420976 .
|
【4】
Keck, J.; et al. (Boehringer Ingelheim GmbH); N-(Hydroxycyclohexyl)aminobenzylamines and the salts thereof. ES 340219; FR 1522709; GB 1178034; US 3536713 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
19581 |
trans-4-Aminocyclohexanol;trans-4-Amino-1-cyclohexanol;trans-4-Amino-1-cyclohexanol; |
27489-62-9 |
C6H13NO |
详情 | 详情
|
(II) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
(III) |
40341 |
2-amino-N-(4-hydroxycyclohexyl)benzamide
|
|
C13H18N2O2 |
详情 |
详情
|
(IV) |
40342 |
4-[(2-aminobenzyl)amino]cyclohexanol
|
|
C13H20N2O |
详情 |
详情
|
合成路线3
该中间体在本合成路线中的序号:
(I) The reaction of isatoic anhydride (I) with glycine ethyl ester (II) gives N-(2-aminobenzoyl)glycine ethyl ester (III), which is cyclized with carbonyldiimidazole (CDI) to yield 2-(2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)acetic acid ethyl ester (IV). The alkylation of (IV) with 3,4-dichlorobenzyl bromide (V) affords 2-[1-(3,4-dichlorobenzyl)-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl]acetic acid ethyl ester (VI), which is finally hydrolyzed in basic medium.
【1】
Itoh, Y.; Hashimoto, M.; Ao, S.; Notsu, Y.; Novel aldose reductase inhibitors: Synthesis and structure-activity studies of (3-benzyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl)acetic acids. Drugs Fut 1992, 17, 1, 31.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
(II) |
10309 |
ethyl 2-aminoacetate; Glycine ethyl ester
|
459-73-4 |
C4H9NO2 |
详情 | 详情
|
(III) |
42909 |
ethyl 2-[(2-aminobenzoyl)amino]acetate
|
|
C11H14N2O3 |
详情 |
详情
|
(IV) |
42910 |
ethyl 2-[2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl]acetate
|
|
C12H12N2O4 |
详情 |
详情
|
(V) |
42911 |
4-(bromomethyl)-1,2-dichlorobenzene
|
18880-04-1 |
C7H5BrCl2 |
详情 | 详情
|
(VI) |
42912 |
ethyl 2-[1-(3,4-dichlorobenzyl)-2,4-dioxo-1,4-dihydro-3(2H)-quinazolinyl]acetate
|
|
C19H16Cl2N2O4 |
详情 |
详情
|
合成路线4
该中间体在本合成路线中的序号:
(VIII) The reaction of 2-nitrobenzoic acid with SOCl2 gives the acyl chloride (II), which is condensed with D-proline (III) by means of TEA in dichloromethane yielding the acyl proline (IV). The reductive cyclization of (IV) with H2 over Pd/C in methanol affords the pyrrolobenzodiazepinedione (V). The selective reduction of the C-11 lactam group of (V) with NaBH4 and TFA in glyme gave the pyrrolobenzodiazepinone (VI), which is finally coupled with 4-[(2-phenylbenzoyl)amino]benzoyl chloride (VII) furnishing the title compound.
【1】
Naito, A.; Ohtake, Y.; Hasegawa, H.; et al.; Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives. Bioorg Med Chem 1999, 7, 6, 1247.
|
【2】
Matsukawa, H.; Toyofuku, H.; Naito, A.; Ohtake, Y.; Saito, Y.; Naito, K. (Wakamoto Pharmaceutical Co., Ltd.); Biphenyl derivs. and medicinal compsns.. EP 0987266; WO 9843976 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20951 |
2-nitrobenzoic acid;o-Nitrobenzoic acid |
552-16-9 |
C7H5NO4 |
详情 | 详情
|
(II) |
21099 |
o-nitrobenzoyl chloride; 2-nitrobenzoyl chloride
|
610-14-0 |
C7H4ClNO3 |
详情 | 详情
|
(III) |
29552 |
methyl (2S)-2-pyrrolidinecarboxylate
|
2133-40-6 |
C6H11NO2 |
详情 | 详情
|
(IV) |
36812 |
methyl (2S)-1-(2-nitrobenzoyl)-2-pyrrolidinecarboxylate
|
|
C13H14N2O5 |
详情 |
详情
|
(V) |
36813 |
(11aS)-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione
|
|
C12H12N2O2 |
详情 |
详情
|
(VI) |
36814 |
(11aS)-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine
|
|
C12H16N2 |
详情 |
详情
|
(VII) |
36810 |
4-[([1,1'-biphenyl]-2-ylcarbonyl)amino]benzoyl chloride
|
|
C20H14ClNO2 |
详情 |
详情
|
(VIII) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
合成路线5
该中间体在本合成路线中的序号:
(VIII) The reaction of 2-nitrobenzoic acid with SOCl2 gives the acyl chloride (II), which is condensed with D-proline (III) by means of TEA in dichloromethane yielding the acyl proline (IV). The reductive cyclization of (IV) with H2 over Pd/C in methanol affords the pyrrolobenzodiazepinedione (V). The reduction of both lactam groups of (V) with LiAlH4 gave the pyrrolobenzodiazepine (VI), which is finally coupled with 4-[(2-phenylbenzoyl)amino]-benzoyl chloride (VII) furnishing the title compound.
【1】
Naito, A.; Ohtake, Y.; Hasegawa, H.; et al.; Novel vasopressin V2 receptor-selective antagonists, pyrrolo[2,1-a]quinoxaline and pyrrolo[2,1-c][1,4]benzodiazepine derivatives. Bioorg Med Chem 1999, 7, 6, 1247.
|
【2】
Matsukawa, H.; Toyofuku, H.; Naito, A.; Ohtake, Y.; Saito, Y.; Naito, K. (Wakamoto Pharmaceutical Co., Ltd.); Biphenyl derivs. and medicinal compsns.. EP 0987266; WO 9843976 .
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
20951 |
2-nitrobenzoic acid;o-Nitrobenzoic acid |
552-16-9 |
C7H5NO4 |
详情 | 详情
|
(II) |
21099 |
o-nitrobenzoyl chloride; 2-nitrobenzoyl chloride
|
610-14-0 |
C7H4ClNO3 |
详情 | 详情
|
(III) |
36811 |
methyl (2R)-2-pyrrolidinecarboxylate
|
|
C6H11NO2 |
详情 |
详情
|
(IV) |
36807 |
methyl (2R)-1-(2-nitrobenzoyl)-2-pyrrolidinecarboxylate
|
|
C13H14N2O5 |
详情 |
详情
|
(V) |
36808 |
(11aR)-2,3-dihydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5,11(10H,11aH)-dione
|
|
C12H12N2O2 |
详情 |
详情
|
(VI) |
36809 |
(11aR)-2,3,5,10,11,11a-hexahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine
|
|
C12H16N2 |
详情 |
详情
|
(VII) |
36810 |
4-[([1,1'-biphenyl]-2-ylcarbonyl)amino]benzoyl chloride
|
|
C20H14ClNO2 |
详情 |
详情
|
(VIII) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
合成路线6
该中间体在本合成路线中的序号:
(I) Condensation of isatoic anhydride (I) with DL-phenylalanine ethyl ester (II) affords anthranilamide (III). Subsequent acylation of amino amide (III) with indole-2-carbonyl chloride (IV) provides diamide (V). The ethyl ester group of (V) is finally hydrolyzed to the target carboxylic acid with methanolic KOH
【1】
Varnavas, A.; Lassiani, L.; Valenta, V.; Berti, F.; Mennuni, L.; Makovec, F.; Anthranilic acid derivatives: A new class of non-peptide CCK1 receptor antagonists. Bioorg Med Chem 2003, 11, 5, 741.
|
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
(II) |
32594 |
methyl 3-(trimethylsilyl)-2-propynoate
|
|
C7H12O2Si |
详情 |
详情
|
(III) |
62746 |
ethyl 2-[(2-aminobenzoyl)amino]-3-phenylpropanoate
|
|
C18H20N2O3 |
详情 |
详情
|
(IV) |
62747 |
1H-indole-2-carbonyl chloride
|
|
C9H6ClNO |
详情 |
详情
|
(V) |
62748 |
ethyl 2-({2-[(1H-indol-2-ylcarbonyl)amino]benzoyl}amino)-3-phenylpropanoate
|
|
C27H25N3O4 |
详情 |
详情
|
合成路线7
该中间体在本合成路线中的序号:
(V) The intermediate anthranilamide (IV) is prepared by two alternative methods. Acylation of 3-(trifluoromethyl)aniline (I) with 2-nitrobenzoyl chloride (II) yields benzamide (III). The nitro group of (III) is then reduced to the corresponding amine (IV) by catalytic hydrogenation over Pd/C (1). Alternatively, 3-(trifluoromethyl)aniline (I) is condensed with isatoic anhydride (V) to furnish directly anthranilamide (IV) (2). Finally, reductive alkylation of (IV) with pyridine-4-carbaldehyde (VI) employing NaBH3CN gives rise to the target pyridylmethyl amine.
【1】
Manley, P.W.; Furet, P.; Bold, G.; Bruggen, J.; Mestan, J.; Meyer, T.; Schnell, C.R.; Wood, J.; Anthranilic acid amides: A novel class of antiangiogenic VEGF receptor kinase inhibitors. J Med Chem 2002, 45, 26, 5687.
|
【2】
Seidelmann, D.; Huth, A.; Manley, P.W.; Thierauch, K.-H.; Krüger, M.; Bold, G.; Haberey, M.; Furet, P.; Altmann, K.-H.; Mestan, J.; Menrad, A.; Ferrari, S.; Wood, J.M.; Hofmann, F. (Novartis AG; Schering AG); N-Aryl(thio)anthranilic acid amide derivs., their preparation and their use as VEGF receptor tyrosine kinase inhibitors. EP 1129075; JP 2002529453; US 6448277; WO 0027820 . |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
26347 |
3-(trifluoromethyl)phenylamine; 3-(trifluoromethyl)aniline; 3-aminobenzotrifluoride
|
98-16-8 |
C7H6F3N |
详情 | 详情
|
(II) |
21099 |
o-nitrobenzoyl chloride; 2-nitrobenzoyl chloride
|
610-14-0 |
C7H4ClNO3 |
详情 | 详情
|
(III) |
64309 |
2-nitro-N-[3-(trifluoromethyl)phenyl]benzamide
|
|
C14H9F3N2O3 |
详情 |
详情
|
(IV) |
64310 |
2-amino-N-[3-(trifluoromethyl)phenyl]benzamide
|
|
C14H11F3N2O |
详情 |
详情
|
(V) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
(VI) |
17203 |
4-Pyridinecarboxaldehyde; isonicotinaldehyde
|
872-85-5 |
C6H5NO |
详情 | 详情
|
合成路线8
该中间体在本合成路线中的序号:
(I)
【1】
Keck J.Synthesis of metabolites of Bisolvon.Liebigs Ann Chem,1967,707:107. |
【2】
Keck J,Koss FW.N-(hydroxy-cyclohexyl)-aminobenzylamines and the salts thereof:US,Patent 3,563,713,1970. |
【3】
Renovanz HD,Pueschmann S,Keck J.N-(hydroxyclohexyl)-2-amino-3,5-dibromobenzylamines as lung therapeutics:DE,Patent 2,207,460,1973. |
中间体序号 |
中间体编号 |
品名 |
CAS号 |
分子式 |
供应商 |
用于合成 |
(I) |
29797 |
2H-3,1-benzoxazine-2,4(1H)-dione;Isatoic anhydride;4H-3,1-Benzoxazine-2,4(1H)-dione;1,2-Dihydro-4H-3,1-benzoxazine-2,4-dione;1H-benzo[d][1,3]oxazine-2,4-dione |
118-48-9 |
C8H5NO3 |
详情 | 详情
|
(II) |
19581 |
trans-4-Aminocyclohexanol;trans-4-Amino-1-cyclohexanol;trans-4-Amino-1-cyclohexanol; |
27489-62-9 |
C6H13NO |
详情 | 详情
|
(III) |
40341 |
2-amino-N-(4-hydroxycyclohexyl)benzamide
|
|
C13H18N2O2 |
详情 |
详情
|